aldoxorubicin
Phase 2- Indications
- Soft tissue sarcoma, Pancreatic cancer
Company intelligence / Profile preview
Hythiam, Inc.
Los Angeles, California, United Statesfiercehealthcare.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Hythiam developed and commercialized the PROMETA protocol for treating alcohol and stimulant dependencies through licensed healthcare providers. The program combined medical supervision with behavioral health management but faced criticism over lack of robust clinical evidence before commercialization. Some studies reported statistically significant results in specific settings. The company was unprofitable throughout its independent existence. In 2011 it rebranded as Catasys to focus on broader behavioral health management solutions for payors.
- Therapeutic areas
- Psychiatry
- Modalities
- Integrated medical and psychosocial interventionsProprietary treatment protocols for substance dependence
- Industry
- Non-Academic Healthcare
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical or biotech partnerships disclosed; worked primarily with health plans/employers/unions as clients/licensees of their programs.
Beyond the preview
Go deeper on Hythiam, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hythiam, Inc..